蓝趾综合征作为视网膜母细胞瘤动脉内化疗的一种并发症。 - Suppr

Suppr

超能文献

Blue toe syndrome as a complication of intra-arterial chemotherapy for retinoblastoma.

作者信息

Sarici Ahmet, Kizilkilic Osman, Celkan Tiraje, Gode Safa

出版信息

JAMA Ophthalmol. 2013 Jun;131(6):801-2. doi: 10.1001/jamaophthalmol.2013.1458.

DOI:10.1001/jamaophthalmol.2013.1458

PMID:23764710

Abstract

摘要

相似文献

Blue toe syndrome as a complication of intra-arterial chemotherapy for retinoblastoma.

JAMA Ophthalmol. 2013 Jun;131(6):801-2. doi: 10.1001/jamaophthalmol.2013.1458.

Blue toe syndrome: a complication of intra-arterial technique, not intra-arterial chemotherapy for retinoblastoma.

JAMA Ophthalmol. 2014 May;132(5):654. doi: 10.1001/jamaophthalmol.2013.6342.

Blue toe syndrome--reply.

JAMA Ophthalmol. 2014 May;132(5):654-5. doi: 10.1001/jamaophthalmol.2013.8252.

Two-dose exposure of intra-arterial chemotherapy for group D retinoblastoma.

J Pediatr Ophthalmol Strabismus. 2012 Mar 27;49 Online:e15-8. doi: 10.3928/01913913-20120320-01.

[Superselective intra-arterial chemotherapy with melphalan for retinoblastoma].

J Fr Ophtalmol. 2014 Feb;37(2):176. doi: 10.1016/j.jfo.2013.05.021. Epub 2013 Nov 7.

Real-time ophthalmoscopic findings of intraophthalmic artery chemotherapy in retinoblastoma.

Arch Ophthalmol. 2012 Aug;130(8):1075-7. doi: 10.1001/archophthalmol.2012.180.

Alternative treatment for retinoblastoma: Intra-arterial chemotherapy with melphalan.

Arch Soc Esp Oftalmol. 2015 Oct;90(10):487-90. doi: 10.1016/j.oftal.2015.04.004. Epub 2015 May 23.

The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma.

Int J Clin Oncol. 2004 Apr;9(2):69-73. doi: 10.1007/s10147-004-0392-6.

Complete regression of retinoblastoma following intra-arterial chemotherapy.

J Pediatr Ophthalmol Strabismus. 2011 Jun 7;48 Online:e23-5. doi: 10.3928/01913913-20110531-02.

A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.

Ophthalmology. 2008 Aug;115(8):1398-404, 1404.e1. doi: 10.1016/j.ophtha.2007.12.014. Epub 2008 Mar 14.

引用本文的文献

Turkish Retinoblastoma Research: A Bibliometric Analysis (1966-2024).

Turk J Ophthalmol. 2024 Oct 25;54(5):282-290. doi: 10.4274/tjo.galenos.2024.43247.

Spotlight on Targeted Chemotherapy in Retinoblastoma: Safety, Efficacy, and Patient Outcomes.

Onco Targets Ther. 2022 Dec 22;15:1545-1561. doi: 10.2147/OTT.S370878. eCollection 2022.

Modern treatment of retinoblastoma: A 2020 review.

Indian J Ophthalmol. 2020 Nov;68(11):2356-2365. doi: 10.4103/ijo.IJO_721_20.

Toe necrosis: report of uncommon aetiology.

BMJ Case Rep. 2019 Jul 12;12(7):e230322. doi: 10.1136/bcr-2019-230322.

Antitumor effect of Quercetin on Y79 retinoblastoma cells via activation of JNK and p38 MAPK pathways.

BMC Complement Altern Med. 2017 Dec 13;17(1):531. doi: 10.1186/s12906-017-2023-6.

Toe Necrosis, Etiologies and Management, a Case Series.

J Am Coll Clin Wound Spec. 2014 Sep 28;5(2):26-35. doi: 10.1016/j.jccw.2014.09.002. eCollection 2013 Aug.

Risk definition and management strategies in retinoblastoma: current perspectives.

Clin Ophthalmol. 2015 Jun 8;9:985-94. doi: 10.2147/OPTH.S59828. eCollection 2015.

An alternative technique of the superselective catheterization of the ophthalmic artery for intra-arterial chemotherapy of the retinoblastoma: retrograde approach through the posterior communicating artery to the ophthalmic artery.

Neuroradiology. 2014 Sep;56(9):751-4. doi: 10.1007/s00234-014-1388-1. Epub 2014 Jun 10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Blue toe syndrome as a complication of intra-arterial chemotherapy for retinoblastoma.

JAMA Ophthalmol. 2013 Jun;131(6):801-2. doi: 10.1001/jamaophthalmol.2013.1458.

Blue toe syndrome: a complication of intra-arterial technique, not intra-arterial chemotherapy for retinoblastoma.

JAMA Ophthalmol. 2014 May;132(5):654. doi: 10.1001/jamaophthalmol.2013.6342.

Blue toe syndrome--reply.

JAMA Ophthalmol. 2014 May;132(5):654-5. doi: 10.1001/jamaophthalmol.2013.8252.

Two-dose exposure of intra-arterial chemotherapy for group D retinoblastoma.

J Pediatr Ophthalmol Strabismus. 2012 Mar 27;49 Online:e15-8. doi: 10.3928/01913913-20120320-01.

[Superselective intra-arterial chemotherapy with melphalan for retinoblastoma].

J Fr Ophtalmol. 2014 Feb;37(2):176. doi: 10.1016/j.jfo.2013.05.021. Epub 2013 Nov 7.

Real-time ophthalmoscopic findings of intraophthalmic artery chemotherapy in retinoblastoma.

Arch Ophthalmol. 2012 Aug;130(8):1075-7. doi: 10.1001/archophthalmol.2012.180.

Alternative treatment for retinoblastoma: Intra-arterial chemotherapy with melphalan.

Arch Soc Esp Oftalmol. 2015 Oct;90(10):487-90. doi: 10.1016/j.oftal.2015.04.004. Epub 2015 May 23.

The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma.

Int J Clin Oncol. 2004 Apr;9(2):69-73. doi: 10.1007/s10147-004-0392-6.

Complete regression of retinoblastoma following intra-arterial chemotherapy.

J Pediatr Ophthalmol Strabismus. 2011 Jun 7;48 Online:e23-5. doi: 10.3928/01913913-20110531-02.

A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.

Ophthalmology. 2008 Aug;115(8):1398-404, 1404.e1. doi: 10.1016/j.ophtha.2007.12.014. Epub 2008 Mar 14.

引用本文的文献

Turkish Retinoblastoma Research: A Bibliometric Analysis (1966-2024).

Turk J Ophthalmol. 2024 Oct 25;54(5):282-290. doi: 10.4274/tjo.galenos.2024.43247.

Spotlight on Targeted Chemotherapy in Retinoblastoma: Safety, Efficacy, and Patient Outcomes.

Onco Targets Ther. 2022 Dec 22;15:1545-1561. doi: 10.2147/OTT.S370878. eCollection 2022.

Modern treatment of retinoblastoma: A 2020 review.

Indian J Ophthalmol. 2020 Nov;68(11):2356-2365. doi: 10.4103/ijo.IJO_721_20.

Toe necrosis: report of uncommon aetiology.

BMJ Case Rep. 2019 Jul 12;12(7):e230322. doi: 10.1136/bcr-2019-230322.

Antitumor effect of Quercetin on Y79 retinoblastoma cells via activation of JNK and p38 MAPK pathways.

BMC Complement Altern Med. 2017 Dec 13;17(1):531. doi: 10.1186/s12906-017-2023-6.

Toe Necrosis, Etiologies and Management, a Case Series.

J Am Coll Clin Wound Spec. 2014 Sep 28;5(2):26-35. doi: 10.1016/j.jccw.2014.09.002. eCollection 2013 Aug.

Risk definition and management strategies in retinoblastoma: current perspectives.

Clin Ophthalmol. 2015 Jun 8;9:985-94. doi: 10.2147/OPTH.S59828. eCollection 2015.

Neuroradiology. 2014 Sep;56(9):751-4. doi: 10.1007/s00234-014-1388-1. Epub 2014 Jun 10.